Aluminum hydroxide + cpg

Aluminum hydroxide + cpg has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Nov 17, 2021: “An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on aluminum hydroxide + cpg

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Baylor University and others
  • 2 of 2 findings with company ties
  • Animals1

What did studies of aluminum hydroxide + cpg find?

2

Studies of aluminum hydroxide + cpg measured 2 outcomes: COVID-19 and anti-RBD neutralizing antibody titers.

COVID-19

downin mice1

1 study
  1. Aluminum hydroxide + cpg protects against COVID-19 in mice (SARS-CoV-2 challenge).

    “protected aged mice from the SARS-CoV-2 challenge”

    AnimalsSARS-CoV-2 challenge

    An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

    Science translational medicine

More on COVID-19

Anti-RBD neutralizing antibody titers

upin mice1

1 study
  1. Aluminum hydroxide + cpg increases anti-RBD neutralizing antibody titers in mice (SARS-CoV-2 challenge) (80-fold increase).

    “AH and CpG adjuvant formulation (AH:CpG) produced an 80-fold increase in anti-RBD neutralizing antibody titers in both age groups relative to AH alone”

    AnimalsSARS-CoV-2 challenge

    An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

    Science translational medicine

More on Anti-RBD neutralizing antibody titers

Latest